| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |